Evidence map›Paper›PMID 23364607›Full record

ArticleJournal of cardiovascular pharmacology2013

Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology.

Ingrid M Bonilla, Arun Sridhar, Yoshinori Nishijima, Sandor Györke, Arturo J Cardounel, Cynthia A Carnes

Abstract read
In one paragraph

Article in Journal of cardiovascular pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Nitric oxide: what's new to NO?American journal of physiology. Cell physiology · 2017
    Review
  3. Article
  4. Article
  5. The NO/ONOO-cycle as the central cause of heart failure.International journal of molecular sciences · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ingrid M BonillaCollege of Pharmacy, Division of Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
Arun Sridhar
Yoshinori Nishijima
Sandor Györke
Arturo J Cardounel
Cynthia A Carnes
Lung Institute · USGlaxoSmithKline (United Kingdom) · GBThe Ohio State University · US

Funding

Ryanodine Receptor Channels in Heart FailureR01HL074045 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GYORKE, SANDOR · 2003 to 2024
$8.2M
Methylarginines and Vascular InjuryR01HL081734 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARDOUNEL, ARTURO J · 2006 to 2014
$2.8M
Heart Failure and Atrial FibrillationR01HL089836 · NHLBI · OHIO STATE UNIVERSITY · PI CARNES, CYNTHIA A · 2008 to 2012
$2.1M
NHLBI NIH HHS HL089836NHLBI NIH HHS R01 HL074045NHLBI NIH HHS R01 HL081734NHLBI NIH HHS R01 HL089836
6 · The paper itself

Abstract

Oxidative stress has been implicated in the pathogenesis of heart failure and atrial fibrillation and can result in increased peroxynitrite production in the myocardium. Atrial and ventricular canine cardiac myocytes were superfused with 3-morpholinosydnonimine-N-ethylcarbamide (SIN-1), a peroxynitrite donor, to evaluate the acute electrophysiologic effects of peroxynitrite. Perforated whole-cell patch clamp techniques were used to record action potentials. SIN-1 (200 µM) increased the action potential duration (APD) in atrial and ventricular myocytes; however, in the atria, APD prolongation was rate independent, whereas in the ventricle APD, prolongation was rate dependent. In addition to prolongation of the action potential, beat-to-beat variability of repolarization was significantly increased in ventricular but not in atrial myocytes. We examined the contribution of intracellular calcium cycling to the effects of SIN-1 by treating myocytes with the SERCA blocker, thapsigargin (5-10 µM). Inhibition of calcium cycling prevented APD prolongation in the atrial and ventricular myocytes, and prevented the SIN-1-induced increase in ventricular beat-to-beat APD variability. Collectively, these data demonstrate that peroxynitrite affects atrial and ventricular electrophysiology differentially. A detailed understanding of oxidative modulation of electrophysiology in specific chambers is critical to optimize therapeutic approaches for cardiac diseases.

Indexed as

Action PotentialsAnimalsAtrial FunctionDogsEnzyme InhibitorsFemaleMaleMolsidomineMyocytes, CardiacNitric Oxide DonorsThapsigarginVentricular FunctionEnzyme InhibitorslinsidomineMolsidomineNitric Oxide DonorsThapsigargin

Identifiers

PMID23364607
PMCPMC3648597
OpenAlexW2319724372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.